Ohne eingeschaltetes JavaScript können Sie PSIAC nicht in vollem Umfang nutzen.
Literaturverzeichnis
Uher R. J Clin Psychiatry. Jun 2020; 81(4)
Pubmed [12914]
Uhr M. J Psychiatr Res. Jan 2007; 41(1-2): 179-88
Pubmed [318]
Ujiie Y. Ther Drug Monit. Jun 2006; 28(3): 299-302
Pubmed [9118]
Ullrich KJ. Kidney Int. Jul 1989; 36(1): 78-88
Pubmed [3463]
Ullrich S. Bioorg Med Chem Lett. Oct 2021; 50: 128333
Pubmed [11382]
Ulrich S. et al., TDM von psychotropen Pharmaka, Psychopharmakotherapie Heft 1/2000 S. 2-14 [3758]
Ulrich S. Eur Neuropsychopharmacol. Aug 2017; 27(8): 697-713
Pubmed [4935]
Ulrich S. Int J Clin Pharmacol Ther. Jan 2003; 41(1): 3-13
Pubmed [1192]
Ulrich S. J Clin Psychopharmacol. Jan 2020; 40(1): 63-74
Pubmed [10538]
Umehara KI. Biopharm Drug Dispos. Mar 2018; 39(3): 152-163
Pubmed [7602]
Unadkat, Chien. Pharm Res (1988)5 (Suppl), S177 [1795]
Ung D. Xenobiotica. Oct 2009; 39(10): 749-56
Pubmed [7364]
Unger M. Drug Metab Rev. Aug 2013; 45(3): 353-85
Pubmed [8012]
Unger NR. Expert Opin Pharmacother. Dec 2016; 17(17): 2359-2370
Pubmed [7245]
Unglaub et al. (2002) Psychiatr Prax 30: Suppl. 2: S121-124 [1163]
Unglaub et al. (2003) Psychiatr Prax 30 (Suppl. 2): S121-S124 [1149]
Unholzer S. Pharmacopsychiatry. Sep 2015; 48(6): 211-4
Pubmed [743]
Unterecker S. Int Clin Psychopharmacol. Jul 2014; 29(4): 206-11
Pubmed , Volltext , DOI [3077]
Unterecker S. J Clin Psychopharmacol. Aug 2013; 33(4): 561-4
Pubmed [4698]
Upadya GM. Indian J Med Sci. Oct 2009; 63(10): 461-3
Pubmed [9154]
Uprima (Apomorphine). Abott Laboratories Ltd. Summary of Product Characteristics, May 2001 [1960]
Uprima (Apomorphine). Abott Laboratories Ltd. Summary of Product Charakteristics, May 2001 [833]
Upton A. Biol Blood Marrow Transplant. Jul 2007; 13(7): 760-4
Pubmed , Volltext , DOI [8241]
Upton RA. Clin Pharmacokinet. Jan 1991; 20(1): 66-80
Pubmed [5711]
Urban AE. Psychiatr Danub. Sep 2015; 27 Suppl 1: S459-61
Pubmed [1142]
Urbanek C, Jockers-Scherübl MC, Vorsicht Pflanze!, NEUROTRANSMITTER 4/2006: 87-88 [3344]
Urbano & Ware (2008) J Clin Psychopharmacol 28:704-705 [2235]
Uriel A. Int J STD AIDS. Dec 2011; 22(12): 768
Pubmed [7116]
Urits I. Neurol Ther. Dec 2020; 9(2): 403-417
Pubmed [13511]
Urits I. Pain Ther. Jun 2020; 9(1): 195-215
Pubmed [13510]
Urva S. J Clin Pharmacol. Apr 2013; 53(4): 444-50
Pubmed [8973]
US-Prescribing information for FIRMAGON® [3874]
Usall J. J Clin Psychiatry. Jun 2014; 75(6): 608-15
Pubmed [9792]
Usiskin SI. Am J Psychiatry. Jun 2000; 157(6): 1021
Pubmed [1114]
Usta NG. Ther Adv Psychopharmacol. Dec 2014; 4(6): 276-81
Pubmed , Volltext , DOI [8155]
Ustianowski A. Expert Rev Anti Infect Ther. Dec 2022; 20(12): 1517-1527
Pubmed [13423]
Üstün Bezgin S. Int Arch Otorhinolaryngol. Jul 2019; 23(3): e267-e275
Pubmed [11409]
Ustuner MA. Tissue Cell. Dec 2017; 49(6): 691-696
Pubmed [11233]
Uthman BM. Epilepsia. Jan 1989; 30 Suppl 2: S33-7
Pubmed [10614]
Uttamsingh V. Drug Metab Dispos. Nov 2005; 33(11): 1723-8
Pubmed [290]
Uzaraga I. Support Care Cancer. Jul 2012; 20(7): 1515-24
Pubmed [12076]
Uzun M. Eur Rev Med Pharmacol Sci. Mar 2009; 13(2): 95-8
Pubmed [10088]
Vadlamudi RS. South Med J. Jul 2007; 100(7): 720-4
Pubmed [6978]
Vadlapatla RK. Expert Opin Drug Metab Toxicol. Apr 2014; 10(4): 561-80
Pubmed , Volltext , DOI [4005]
Vaduganathan M. J Card Fail. Nov 2021; 27(11): 1280-1284
Pubmed [12674]
Vaidyanathan S. Clin Pharmacokinet. Jan 2008; 47(8): 515-31
Pubmed [8099]
Vainer JL, Chouinard G. Caffeine and antipsychotics. Clin Invest Med (1993) 16 (Suppl 4), B20 [1097]
Vainer JL. J Clin Psychopharmacol. Aug 1994; 14(4): 284-5
Pubmed [1094]
Vairo G. J Med. Jan 1984; 15(1): 75-80
Pubmed [10490]
Vakkalagadda B. Am J Cardiovasc Drugs. Apr 2016; 16(2): 119-27
Pubmed [6139]
Vakkalagadda et al. Am J Cardiovasc Drugs. 2016 Jan 9 [4138]
Valassi E. J Clin Endocrinol Metab. Mar 2010; 95(3): 1025-33
Pubmed [10949]
Valdes L. Arch Pediatr. Jun 1997; 4(6): 535-7
Pubmed [8948]
Valdes M. J Affect Disord. Mar 2019; 246: 861-866
Pubmed [9888]
Vale JA. Lancet. Jun 1991; 337(8756): 1552
Pubmed [1279]
Valin N. J Int Assoc Physicians AIDS Care (Chic). Mar 2009; 8(2): 113-21
Pubmed [6380]
Valk-Swinkels CG. Ned Tijdschr Geneeskd. Jan 2013; 157(28): A5667
Pubmed [6215]
Vallée A. Aging (Albany NY). Feb 2020; 12(3): 3095-3113
Pubmed [11454]
Vallejo R. Pain Physician. Jul 2011; 14(4): E343-60
Pubmed [3301]
Valsalan VC. Br Med J (Clin Res Ed). Jul 1982; 285(6337): 261-2
Pubmed , Volltext [6788]
Van Berkel MA. Pharmacotherapy. Jun 2013; 33(6): e96-100
Pubmed [6132]
van Breemen RB. Fitoterapia. Jan 2011; 82(1): 38-43
Pubmed [12297]
van Breemen RB. J Agric Food Chem. May 2020; 68(18): 5212-5220
Pubmed [9109]
van de Wetering-Krebbers SF. Drug Metab Dispos. Apr 2011; 39(4): 580-90
Pubmed [250]
van den Bemt PM. Pharm World Sci. Oct 2002; 24(5): 201-4
Pubmed [11830]
van den Berg MJ. Am J Ther. Jan 2016; 23(1): e246-8
Pubmed [1592]
Van den Bergh A. Clin Pharmacokinet. Sep 2020; 59(9): 1149-1160
Pubmed [11495]
Van der Auwera P. J Antimicrob Chemother. Nov 1993; 32 Suppl B: 103-15
Pubmed [5908]
van der Bol JM. Clin Cancer Res. Jan 2010; 16(2): 736-42
Pubmed [5010]
Van der Heijden KB. J Am Acad Child Adolesc Psychiatry. Feb 2007; 46(2): 233-41
Pubmed [11710]
van der Klauw MM. Arch Intern Med. Feb 1999; 159(4): 369-74
Pubmed [9089]
van der Lee M. Antivir Ther. Jan 2007; 12(7): 1127-32
Pubmed [6482]
van der Lee MJ. Antimicrob Agents Chemother. Nov 2007; 51(11): 4098-104
Pubmed , Volltext , DOI [10143]
van der Lee MJ. Clin Pharmacol Ther. Aug 2006; 80(2): 159-68
Pubmed [8755]
van der Sandt IC. AIDS. Mar 2001; 15(4): 483-91
Pubmed [4997]
van der Velden W. Neth J Med. May 2008; 66(5): 204-6
Pubmed [5870]
van der Watt JJ. Int J Tuberc Lung Dis. Nov 2015; 19(11): 1312-9
Pubmed [9404]
van der Weide K. J Clin Psychopharmacol. Jun 2015; 35(3): 228-36
Pubmed [193]
van der Zalm IJB. J Med Case Rep. Jun 2020; 14(1): 83
Pubmed [11309]
van Dijkman SC. Br J Clin Pharmacol. Jan 2018; 84(1): 97-111
Pubmed , Volltext , DOI [9427]
Van Es MA. Amyotroph Lateral Scler Frontotemporal Degener. Nov 2020; 21(7-8): 584-592
Pubmed [11457]
van Giersbergen PL. Clin Pharmacol Ther. Mar 2007; 81(3): 414-9
Pubmed [4289]
van Giersbergen PL. Int J Clin Pharmacol Ther. Mar 2006; 44(3): 113-8
Pubmed [4287]
van Gorp F. Br J Clin Pharmacol. Mar 2012; 73(3): 402-10
Pubmed [13801]
van Haarst AD. Clin Pharmacol Ther. Nov 1998; 64(5): 542-6
Pubmed [5324]
van Harten et al. Eur Neuropsychopharmacol (1992) 2, 381 [1462]
van Harten J. Clin Pharmacokinet. Jan 1995; 29 Suppl 1: 1-9
Pubmed [325]
van Harten J. Clin Pharmacol Ther. Oct 1992; 52(4): 427-35
Pubmed [1457]
van Heeswijk RP. Antivir Ther. Jan 2013; 18(4): 553-60
Pubmed [6322]
van Heeswijk RP. J Antimicrob Chemother. Sep 2014; 69(9): 2310-8
Pubmed [5184]
van Heeswijk RP. J Clin Pharmacol. Jul 2006; 46(7): 758-67
Pubmed [461]
Van Heeswijk, R.; Boogaerts, G.; De Paepe, E.; Van Solingen-Ristea, R.; Garg, V.; Beumont, M., The pharmacokinetic interaction between escitalopram and the investigational HCV protease inhibitor telaprevir [abstract 12]. 5th International Workshop on Clinical Pharmacology of Hepatitis Therapy; Boston, MA. June 23–24, 2010;. [7391]
Van Heeswijk, R.; Boogaerts, G.; De Paepe, E.; Van Solingen-Ristea, R.; Garg, V.; Beumont, M., The pharmacokinetic interaction between escitalopram and the investigational HCV protease inhibitor telaprevir [abstract 12]. 5th International Workshop on Clinical Pharmacology of Hepatitis Therapy; Boston, MA. June 23–24, 2010;. [7392]
Bildrechte: © spinetta / Fotolia